Microbiologic profile and clinical practices in urinary tract infections in a tertiary care center in Southern India.
Antibiotic sensitivity
diabetes mellitus
empirical treatment
urinary tract infections
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
28
04
2019
revised:
29
04
2019
accepted:
10
06
2019
entrez:
5
11
2019
pubmed:
5
11
2019
medline:
5
11
2019
Statut:
epublish
Résumé
Studies reported differences in clinical profiles of urinary tract infections (UTIs) in patients with and without type 2 diabetes mellitus (T2DM). Studies on the impact of the pattern of antibiotic resistance of organisms causing UTI on actual clinical practice are lacking. 1. To study the clinical and microbiologic profiles of UTIs. 2. To compare treatment given with the prevailing antimicrobial sensitivity. This is a cross-sectional study conducted in a tertiary care hospital. Retrospective chart review of inpatients with UTI (N = 200, 100 each of patients with and without T2DM), aged >18 years with a positive urine culture. We used the statistical package SPSS version 17. The categorical variables were analyzed by the Chi-square test. Data were considered significant if Similar to previous Indian studies, T2DM patients with UTI had significantly more asymptomatic bacteriuria, asymptomatic bacteriuria (32% vs. 6%), previous history of UTI (25% vs. 2%), and prior catheterization (16% vs. 1%). Escherichia coli ( Ceftriaxone is the most common empirical therapy given in spite the prevailing low sensitivity of E. coli to it. Cases of ASB were treated unlike recommendations.
Identifiants
pubmed: 31681661
doi: 10.4103/jfmpc.jfmpc_346_19
pii: JFMPC-8-2888
pmc: PMC6820372
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2888-2892Informations de copyright
Copyright: © 2019 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Clin Infect Dis. 2005 Mar 1;40(5):643-54
pubmed: 15714408
Am J Epidemiol. 2005 Mar 15;161(6):557-64
pubmed: 15746472
J Family Med Prim Care. 2019 Jan;8(1):154-159
pubmed: 30911498
Diabetologia. 1971 Oct;7(5):297-301
pubmed: 5134251
Ann Intern Med. 2005 Jan 4;142(1):20-7
pubmed: 15630106
J Infect Dev Ctries. 2008 Oct 01;2(5):354-8
pubmed: 19745502
Clin Infect Dis. 2005 Aug 1;41(3):281-8
pubmed: 16007521
J Infect. 2014 Sep;69(3):244-51
pubmed: 24854421
Ann Clin Microbiol Antimicrob. 2007 Mar 23;6:4
pubmed: 17378940
Infection. 2014 Dec;42(6):1013-22
pubmed: 25143193
Diabetes Care. 2000 Jun;23(6):744-9
pubmed: 10840989
Arch Intern Med. 2006 Nov 13;166(20):2222-7
pubmed: 17101940
J Diabetes Complications. 2014 Nov-Dec;28(6):805-10
pubmed: 25161100
J Am Geriatr Soc. 2009 Nov;57(11):2125-8
pubmed: 20121956
Diabetes Care. 2011 Jan;34(1):230-5
pubmed: 20937688
Indian J Med Res. 2014 Jun;139(6):945-8
pubmed: 25109731
Indian J Endocrinol Metab. 2013 May;17(3):442-5
pubmed: 23869299
Diabetologia. 2007 Mar;50(3):549-54
pubmed: 17187246
N Engl J Med. 2002 Nov 14;347(20):1576-83
pubmed: 12432044
Diabetes Care. 2002 Aug;25(8):1405-9
pubmed: 12145242
Australas Med J. 2014 Jan 31;7(1):29-34
pubmed: 24567764
Fam Pract. 2010 Aug;27(4):379-85
pubmed: 20462975